Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axsome Thera (NQ: AXSM )

75.78 +0.98 (+1.31%)
Streaming Delayed Price Updated: 11:54 AM EDT, May 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axsome Thera

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Axsome Therapeutics to Present at the Bank of America Securities 2023 Healthcare Conference
From Axsome Therapeutics, Inc.
Via GlobeNewswire
Axsome Therapeutics Joins Mental Health America and the State of New York to Raise Awareness of Mental Health During May is Mental Health Month
One World Trade Center to be lit up in green in observance of Mental Health Month 
From Axsome Therapeutics, Inc.
Via GlobeNewswire
The 3 Most Promising Biotech Innovations in 2023 and the Stocks to Buy
Here are three biotech stocks with promising innovations that could provide catalysts for their respective stocks in 2023 
Via InvestorPlace
NASDAQ: AXSM Shareholder Notice: Investigation over Potential Wrongdoing at Axsome Therapeutics, Inc.
San Diego, CA -- (SBWIRE) -- 04/27/2023 -- Certain directors of Axsome Therapeutics, Inc. are under investigation over potential breaches of fiduciary duties. 
Via SBWire
Axsome Therapeutics Stock: Bear vs. Bull
Axsome shares beat the bear market last year. 
Via The Motley Fool
2 Beaten-Down Growth Stocks to Buy in April
These companies have lucrative opportunities ahead. 
Via The Motley Fool
Could Axsome Therapeutics Stock Help You Become a Millionaire?
In the past five years, the stock has risen by nearly 2,400%. 
Via The Motley Fool
3 Biotech Stocks to Watch After Johnson & Johnson’s Earnings Beat
Discover the latest picks in the biotech industry with our article on 3 biotech stocks to watch after Johnson & Johnson’s earnings beat. 
Via InvestorPlace
If You Invested $5,000 in Axsome Therapeutics 5 Years Ago, Here's How Much You Would Have Now
Axsome's new products have blockbuster potential. 
Via The Motley Fool
3 Stocks With Huge Catalysts on the Way
Big news could mean big boosts for these stocks. 
Via The Motley Fool
Axsome Therapeutics to Present Five Abstracts Including New Data from the Positive SHARP Study of SUNOSI® (solriamfetol) in Participants with Cognitive Impairment with Excessive Daytime Sleepiness in Obstructive Sleep Apnea at the 2023 American Academy of
From Axsome Therapeutics, Inc.
Via GlobeNewswire
Is It Too Late to Buy Axsome Therapeutics Stock?
With two major catalysts in the rearview mirror, it's easy to think that it's too late. 
Via The Motley Fool
What 10 Analyst Ratings Have To Say About Axsome Therapeutics
Via Benzinga
The Top 3 Biotech Stocks to Watch in 2023
Investors would be wise to keep an eye on the biotech boom, and these top biotech stocks to watch as we get deeper into 2023. 
Via InvestorPlace
1 Risky Growth Stock Wall Street Says Is Poised for a 47% Rally
Its price should keep rising, but perhaps Wall Street is a bit enthusiastic with its forecasts. 
Via The Motley Fool
The Top Healthcare Stocks to Buy With $100
A small investment now may bring big results over time. 
Via The Motley Fool
Better Growth Stock: Axsome vs. CRISPR Therapeutics
These companies are both in the early days of their growth stories. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Axsome Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
From Axsome Therapeutics, Inc.
Via GlobeNewswire
Axsome Therapeutics to Report First Quarter 2023 Financial Results on May 8
Axsome to host conference call and webcast on Monday, May 8, 2023, at 8:00 a.m. Eastern Time 
From Axsome Therapeutics, Inc.
Via GlobeNewswire
These Up-and-Coming Stocks Are Screaming Buys Right Now
Both companies could deliver revenue and share price growth over the long term. 
Via The Motley Fool
Can Axsome Hold Out Till Depression Drug Becomes a Blockbuster?
Has the company bitten off more than it can chew in R&D, or will its depression drug launch it into the stratosphere? 
Via The Motley Fool
A New Nasdaq Bull Market Is Nearly Here: 3 Stocks to Buy Sooner Rather Than Later
These stocks share one big thing in common -- huge growth prospects. 
Via The Motley Fool
Has Axsome Therapeutics Become a No-Brainer Buy?
The stock has been red-hot over the past year, and analysts remain bullish on it. 
Via The Motley Fool
Why Agenus, Amarin, and Axsome Therapeutics Shares Slumped Today
Macro headwinds are weighing on risk-laden biotech stocks today. 
Via The Motley Fool
2 Top Biotech Stocks to Buy in April
Right now you can pick up these stocks on the dip. 
Via The Motley Fool
3 Surprisingly Underrated Stocks to Buy in April
These drugmakers could deliver greater gains than many investors expect. 
Via The Motley Fool
The Top Healthcare Stocks to Buy With $100
With the right stocks, even a small investment can yield huge returns. 
Via The Motley Fool
The 3 Best Growth Stocks to Buy in the Biotech Sector
These three biotech growth stocks are brimming with potential and could offer massive upside for patient investors. 
Via InvestorPlace
3 Up-and-Coming Growth Stocks to Buy Right Now
These companies are small now but could grow much larger over time. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.